Pamrevlumab (FG-3019) is a human antibody with affinity for connective tissue growth factor (CTGF) and is involved in anti-CTGF therapy for the treatment of idiopathic pulmonary fibrosis (IPF).
CAS Number:
[946415-13-0]
Target:
Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted